Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors

NCT03324113 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm Malignant

Interventions

DRUG: SAR408701
DRUG: dexamethasone
DRUG: naphazoline
DRUG: diphenhydramine

Sponsor

Sanofi